Cytochrome c oxidase and its role in neurodegeneration and neuroprotection

Advances in Experimental Medicine and Biology

Volumn 748, Issue , 2012, Pages 305-339

  Arnold, Susanne ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BILOBALIDE; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE IV 1; CYTOCHROME C OXIDASE IV 2; GINKGO BILOBA EXTRACT; GLUTATHIONE; HERBACEOUS AGENT; ISOENZYME; OXYGEN; REACTIVE OXYGEN METABOLITE; STEROID; TOXIN; UNCLASSIFIED DRUG;

AGING; ALLOSTERISM; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOSYNTHESIS; BRAIN INFARCTION; BRAIN MITOCHONDRION; CALORIC RESTRICTION; CELL COMMUNICATION; CELL NUCLEUS; CELL TYPE; DEGENERATION; DIET SUPPLEMENTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; FEEDBACK SYSTEM; HUMAN; HUNTINGTON CHOREA; HYPOXIA; MAMMAL; METABOLIC REGULATION; NERVE CELL; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; OXYGEN SENSING; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RESPIRATORY CHAIN; SEX; SIGNAL TRANSDUCTION; TOXICITY; UPREGULATION;

ADENOSINE TRIPHOSPHATE; AGING; ALLOSTERIC REGULATION; ANIMALS; CELL COMMUNICATION; ELECTRON TRANSPORT COMPLEX IV; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84863751490     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3573-0_13     Document Type: Article

References (241)

1. Abraham CR, Marshall DC, Tibbles HE, Otto K, Long HJ, Billingslea AM, Hastey R, Johnson R, Fine RE, Smith SJ, Simons ER, Davies TA (1999) Platelets and DAMI megakaryocytes possess beta-secretase-like activity. J Lab Clin Med 133:507-515
2. Allen LA, Zhao XJ, Caughey W, Poyton RO (1995) Isoforms of yeast cytochrome c oxidase subunit V affect the binuclear reaction center and alter the kinetics of interaction with the isoforms of cytochrome c. J Biol Chem 270:110-118
3. Antonini G, Malatesta F, Sarti P, Vallone B, Brunori M (1988) ATP-induced spectral changes in cytochrome c oxidase. A kinetic investigation. Biochem J 256:835-840
4. Araujo GW, Beyer C, Arnold S (2008) Oestrogen in fluences on mitochondrial gene expression and respiratory chain activity in cortical and mesencephalic astrocytes. J Neuroendocrinol 20:930-941
5. Arnold S (2012) The power of life - cytochrome c oxidase takes center stage in metabolic control, cell signalling and survival. Mitochondrion 12:46-56
6. Arnold S, Beyer C (2009) Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. J Neurochem 110:1-11
7. Arnold S, Kadenbach B (1997) Cell respiration is controlled by ATP, an allosteric inhibitor of cytochrome c oxidase. Eur J Biochem 249:350-354
8. Arnold S, Kadenbach B (1999) The intramitochondrial ATP/ADP ratio controls cytochrome c oxidase activity allosterically. FEBS Lett 443:105-108
9. Arnold S, Goglia F, Kadenbach B (1998) 3,5-Diiodothyronine binds to subunit Va of cytochrome c oxidase and abolishes the allosteric inhibition of respiration by ATP. Eur J Biochem 252:325-330
10. Arnold S, de Ara'jo GW, Beyer C (2008) Gender-specific regulation of mitochondrial fusion and fission gene transcription and viability of cortical astrocytes by steroid hormones. J Mol Endocrinol 41:289-300
11. Arnold S, Victor MB, Beyer C (2012) Estrogen and the regulation of mitochondrial structure and function in the brain. J Steroid Biochem Mol Biol (in press)
12. Atamna H (2006) Heme binding to amyloid- b peptide: mechanistic role in Alzheimer's disease. J Alzheimers Dis 10:255-266
13. Atamna H (2009) Amino acids variations in amyloid-beta peptides, mitochondrial dysfunction, and new therapies for Alzheimer's disease. J Bioenerg Biomembr 41:457-464
14. Atamna H, Frey WH II (2004) A role for heme in Alzheimer's disease: heme binds amyloid b and has altered metabolism. Proc Natl Acad Sci USA 101:11153-11158
15. Atlante A, Amadoro G, Bobba A, de Bari L, Corsetti V, Pappalardo G, Marra E, Calissano P, Passarella S (2008) A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator. Biochim Biophys Acta 1777:1289-1300
16. Ayala A, Venero JL, Cano J, Machado A (2007) Mitochondrial toxins and neurodegenerative diseases. Front Biosci 12:986-1007
17. Babcock GT, Wikstrom M (1992) Oxygen activation and the conservation of energy in cell respiration. Nature 356:301-309
18. Bandyopadhyay B, Li G, Yin H, Kuret J (2007) Tau aggregation and toxicity in a cell culture model of tauopathy. J Biol Chem 282:16454-16464
19. Banerjee R, Starkov AA, Beal MF, Thomas B (2009) Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim Biophys Acta 1792:651-663
20. Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366
21. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495-505
22. Beauchemin AMJ, Gottlieb B, Beitel LK, Elhaji YA, Pinsky L, Tri firo MA (2001) Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy. Brain Res Bull 56:285-297
23. Beauvoit B, Rigoulet M (2001) Regulation of cytochrome c oxidase by adenylic nucleotides. Is oxidative phosphorylation feedback regulated by its end-products? IUBMB Life 52:143-152
24. Benzi G, Pastoris O, Marzatico F, Villa RF, Dagani F, Curti D (1992) The mitochondrial electron transfer alteration as a factor involved in the brain aging. Neurobiol Aging 13:361-368
25. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455
26. Bertoni-Freddari C, Fattoretti P, Giorgetti B, Solazzi M, Balietti M, Casoli T, Di SG (2004) Cytochrome oxidase activity in hippocampal synaptic mitochondria during aging: a quantitative cytochemical investigation. Ann N Y Acad Sci 1019:33-36
27. Bettini E, Maggi A (1992) Estrogen induction of cytochrome c oxidase subunit III in rat hippocampus. J Neurochem 58:1923-1929
28. Bisson R, Schiavo G, Montecucco C (1987) ATP induces conformational changes in mitochondrial cytochrome c oxidase. Effect on the cytochrome c binding site. J Biol Chem 262:5992-5998
29. Bolanos JP, Heales SJR, Land JM, Clark JB (1995) Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J Neurochem 64:1965-1972
30. Bonilla E, Tanji K, Hirano M, Vu TH, DiMauro S, Schon EA (1999) Mitochondrial involvement in Alzheimer's disease. Biochim Biophys Acta 1410:171-182
31. Borlongan CV, Koutouzis TK, Randall TS, Freeman TB, Cahill DW, Sanberg PR (1995) Systemic 3-nitropropionic acid: behavioural deficits and striatal damage in adult rats. Brain Res Bull 36:549-556
32. Borlongan CV, Koutouzis TK, Sanberg PR (1997) 3-Nitropropionic acid animal model and Huntington's disease. Neurosci Biobehav Rev 21:289-293
33. Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA, Murri L, Rapoport SI, Solaini G (2002) Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 23:371-376
34. Boutin AT, Johnson RS (2007) Waiting to inhale: HIF-1 modulates aerobic respiration. Cell 129:29-30
35. Boveris A, Chance B (1973) The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134:707-716
36. Boveris A, Costa LE, Cadenas E (1999) The mitochondrial production of oxygen radicals and cellular aging. In: Cadenas E, Packer L (eds) Understanding the process of aging: the roles of mitochondria, free radicals, and antioxidants, vol 8, Antioxidants in health and disease. Dekker, New York, pp 1-20
37. Boyalla SS, Victor MB, Roemgens A, Beyer C, Arnold S (2011) Gender- and brain region-specific role of cytochrome c oxidase in 1-methyl-4- phenylpyridinium-mediated astrocyte vulnerability. J Neurosci Res 89:2068-2082
38. Brennan WA, Bird ED, Aprille JR (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 44:1948-1950
39. Brinton RD (2008) The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci 31:529-537
40. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646-653
41. Burke PV, Poyton RO (1998) Structure/function of oxygen-regulated isoforms in cytochrome c oxidase. J Exp Biol 201:1177-1195
42. Cadenas E, Boveris A, Ragan CI, Stoppani AO (1977) Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys 180:248-257
43. Canevari L, Clark JB, Bates TE (1999) Beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett 457:131-134
44. Capaldi RA (1990) Structure and function of cytochrome c oxidase. Annu Rev Biochem 59:569-596
45. Cardoso SM, Proen'a MT, Santos S, Santana I, Oliveira CR (2004) Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 25:105-110
46. Carri MT, Ferri A, Battistoni A, Famhy L, Gabbianelli R, Poccia F, Rotilio G (1997) Expression of a Cu, Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca 2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett 414:365-368
47. Chagnon P, Betard C, Robitaille Y, Cholette A, Gauvreau D (1995) Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport 6:711-715
48. Chance B, Williams CR (1955) Respiratory enzymes in oxidative phosphorylation. III. The steady state. J Biol Chem 217:409-427
49. Chandrasekaran K, Hatanpaa K, Brady DR, Stoll J, Rapoport SI (1998) Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex. Brain Res 796:13-19
50. Chen M, Durr J, Fernandez HL (2000) Possible role of calpain in normal processing of betaamyloid precursor protein in human platelets. Biochem Biophys Res Commun 273:170-175
51. Chen JQ, Yager JD, Russo J (2005) Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta 1746:1-17
52. Chen JQ, Cammarata PR, Baines CP, Yager JD (2009) Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta 1793:1540-1570
53. Chinnery PF, Turnbull DM (1999) Mitochondrial DNA and disease. Lancet 354:17-21
54. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1162-1166
55. Collman JP, Ghosh S, Dey A, Decreau RA (2009) Using a functional enzyme model to understand the chemistry behind hydrogen sul fide induced hibernation. Proc Natl Acad Sci USA 106:22090-22095
56. Cooper CE, Davies NA (2000) Effects of nitric oxide and peroxynitrite on the cytochrome oxidase Km for oxygen: implications for mitochondrial pathology. Biochim Biophys Acta 1459:390-396
57. Cottrell DA, Blakely EL, Johnson MA, Ince PG, Borthwick GM, Turnbull DM (2001) Cytochrome c oxidase deficient cells accumulate in the hippocampus and choroid plexus with age. Neurobiol Aging 22:265-272
58. Curti D, Rognaoni F, Gasparini L, Cattaneo A, Paolillo M, Racchi M, Zani L, Trabucchi M, Bergamaschi S, Govoni S (1997) Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients. Neurosci Lett 236:13-16
59. Dalmonte ME, Forte E, Genova ML, Giuffre A, Sarti P, Lenaz G (2009) Control of respiration by cytochrome c oxidase in intact cells: role of the membrane potential. J Biol Chem 284:32331-32335
60. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909
61. Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, Hirano M, DiMauro S (2006) Earlyonset familial parkinsonism due to POLG mutations. Ann Neurol 59:859-862
62. Davies TA, Long HJ, Sgro K, Rathbun WH, McMenamin ME, Seetoo K, Tibbles H, Billingslea AM, Fine RE, Fishman JB, Levesque CA, Smith SJ, Wells JM, Simons ER (1997) Activated Alzheimer disease platelets retain more beta amyloid precursor protein. Neurobiol Aging 18:147-153
63. Defeudis FV (2002) Bilobalide and neuroprotection. Pharmacol Res 46:565-568
64. Demonacos C, Djordjevic-Markovic R, Tsawdaroglou N, Sekeris CE (1995) The mitochondrion as a primary site of action of glucocorticoids: the interaction of the glucocorticoid receptor with mitochondrial DNA sequences showing partial similarity to the nuclear glucocorticoid responsive elements. J Steroid Biochem Mol Biol 55:43-55
65. Demonacos CV, Karayanni N, Hatzoglou E, Tsiriyiotis C, Spandidos DA, Sekeris CE (1996) Mitochondrial genes as sites of primary action of steroid hormones. Steroids 61:226-232
66. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26:9057-9068
67. Dhar SS, Ongwijitwat S, Wong-Riley MT (2008) Nuclear respiratory factor 1 regulates all ten nuclear encoded subunits of cytochrome c oxidase in neurons. J Biol Chem 283:3120-3129
68. Diaz F, Villena A, Requena V, Gonzalez P, Pelaez A, Perez de Vargas I (1996) Quantitative histochemical study of cytochrome oxidase in the dLGN of aging rats. Mech Ageing Dev 91:47-54
69. DiDonato S, Zeviani M, Giovannini P, Savarese N, Rimoldi M, Mariotti C, Girotti F, Caraceni T (1993) Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology 43:2262-2268
70. Dluzen DE, McDermott JL (2000) Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease. J Gend Specif Med 3:36-42
71. Dodson MW, Guo M (2007) Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol 17:331-337
72. Drose S, Brandt U (2008) The mechanism of mitochondrial superoxide production by cytochrome bc1 complex. J Biol Chem 283:21649-21654
73. Dykens JA, Moos WH, Howell N (2005) Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study. Ann N Y Acad Sci 1052:116-135
74. Eckert A, Hauptmann S, Scherping I, Rhein V, Muller-Spahn F, Gotz J, Muller WE (2008) Soluble betaamyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener Dis 5:157-159
75. Fahn S, Sulzer D (2004) Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx 1:139-154
76. Ferguson-Miller S, Babcock GT (1996) Heme/copper terminal oxidases. Chem Rev 96:2889-2908
77. Folbergrova J, Jesina P, Haugvicova R, Lisy V, Houst KJ (2010) Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid. Neurochem Int 56:394-403
78. Forman HJ, Fukuto JM, Miller T, Zhang H, Rinna A, Levy S (2008) The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch Biochem Biophys 477:183-195
79. Frank V, Kadenbach B (1996) Regulation of the H + /e - -stoichiometry of cytochrome c oxidase from bovine heart by intraliposomal ATP/ADP ratios. FEBS Lett 382:121-124
80. Frenzel M, Rommelspacher H, Sugawa MD, Dencher NA (2010) Ageing alters the supramolecular architecture of OxPhos complexes in rat brain cortex. Exp Gerontol 45:563-572
81. Fujita K, Yamauchi M, Shibayama K, Ando M, Honda M, Nagata Y (1996) Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis. J Neurosci Res 45:276-281
82. Fukada K, Zhang F, Vien A, Cashman NR, Zhu H (2004) Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis. Mol Cell Proteomics 3:1211-1223
83. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL (2007) HIF-1 regulates cytochrome c oxidase subunits to optimize ef ficiency of respiration in hypoxic cells. Cell 129:111-122
84. Fukui H, Moraes CT (2008) The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 31:251-256
85. Gould E, McEwen BS (1993) Neuronal birth and death. Curr Opin Neurobiol 3:676-682
86. Gour finkel-An I, Vila M, Faucheux B, Duyckaerts C, Viallet F, Hauw JJ, Brice A, Agid Y, Hirsch EC (2002) Metabolic changes in the basal ganglia of patients with Huntington's disease: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurochem 80:466-476
87. Greene JG, Porter RH, Eller RV, Greenamyre JT (1993) Inhibition of succinate dehydrogenase by malonic acid produces an excitotoxic lesion in rat striatum. J Neurochem 61:1151-1154
88. Groen AK, Wanders RJA, Westerhoff HV, van der Meer R, Tager JM (1982) Quantification of the contribution of various steps to the control of mitochondrial respiration. J Biol Chem 257:2754-2757
89. Grossman LI, Lomax MI (1997) Nuclear genes for cytochrome c oxidase. Biochim Biophys Acta 1352:174-192
90. Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39:385-389
91. Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, Booij J, Dluzen DE, Horstink MW (2007) Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 78:819-824
92. Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609-1623
93. Harman D (1972) The biologic clock: the mitochondria? J Am Geriatr Soc 20:145-147
94. Hatzoglou E, Sekeris CE (1997) The detection of nucleotide sequences with strong similarity to hormone responsive elements in the genome of eubacteria and archaebacteria and their possible relation to similar sequences present in the mitochondrial genome. J Theor Biol 184:339-344
95. Hauptmann S, Keil U, Scherping I, Bonert A, Eckert A, Muller WE (2006) Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease. Exp Gerontol 41:668-673
96. Helling S, Vogt S, Rhiel A, Ramzan R, Wen L, Marcus K, Kadenbach B (2008) Phosphorylation and kinetics of mammalian cytochrome c oxidase. Mol Cell Proteomics 7:1714-1724
97. Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4:600-609
98. Hendler RW, Pardhasaradhi K, Reynafarje B, Ludwig B (1991) Comparison of energy-transducing capabilities of the two- and three-subunit cytochromes aa3 from Paracoccus denitrificans and the 13-subunit beef heart enzyme. Biophys J 60:415-423
99. Hevner RF, Wong-Riley MTT (1989) Brain cytochrome oxidase: puri fication, antibody production, and immunohistochemical/histochemical correlations in the CNS. J Neurosci 9:3884-3898
100. Hevner RF, Liu S, Wong-Riley MT (1995) A metabolic map of cytochrome oxidase in the rat brain: histochemical, densitometric and biochemical studies. Neuroscience 65:313-342
101. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21:3017-3023
102. Hirano A, Nakano I, Kurland LT, Mulder DW, Holley PW, Saccomanno G (1984) Fine structural study of neuro fibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 43:471-480
103. Horvat S, Beyer C, Arnold S (2006) Effect of hypoxia on the transcription pattern of subunit isoforms and the kinetics of cytochrome c oxidase in cortical astrocytes and cerebellar neurons. J Neurochem 99:937-951
104. Hsieh YC, Yu HP, Suzuki T, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH (2006) Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following traumahemorrhage. J Mol Cell Cardiol 41:511-521
105. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983
106. Huttemann M, Kadenbach B, Grossman LI (2001) Mammalian subunit IV isoforms of cytochrome c oxidase. Gene 267:111-123
107. Huttemann M, Jaradat S, Grossman LI (2003a) Cytochrome c oxidase of mammals contains a testes-specific isoform of subunit VIb - the counterpart to testes-specific cytochrome c? Mol Reprod Dev 66:8-16
108. Huttemann M, Schmidt TR, Grossman LI (2003b) A third isoform of cytochrome c oxidase subunit VIII is present in mammals. Gene 312:95-102
109. Huttemann M, Lee I, Liu J, Grossman LI (2007) Transcription of mammalian cytochrome c oxidase subunit IV-2 is controlled by a novel conserved oxygen responsive element. FEBS J 274:5737-5748
110. Ikebe S, Tanaka M, Ohno K, Sato W, Hattori K, Kondo T, Mizuno Y, Ozawa T (1990) Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 170:1044-1048
111. Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RD, Nilsen J (2008) Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 149:3167-3175
112. Itoh K, Weis S, Mehraein P, Muller-Hocker J (1996) Cytochrome c oxidase defects of the human substantia nigra in normal aging. Neurobiol Aging 17:843-848
113. Jackson M, Al-Chalabi A, Enayat ZE, Chioza B, Leigh PN, Morrison KE (1997) Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and Identification of an ovelinsertion mutation. Ann Neurol 42:803-807
114. Johann S, Dahm M, Kipp M, Beyer C, Arnold S (2010) Oestrogen regulates mitochondrial respiratory chain enzyme transcription in the mouse spinal cord. J Neuroendocrinol 22:926-935
115. Kadenbach B (1986) Regulation of respiration and ATP synthesis in higher organisms: hypothesis. J Bioenerg Biomembr 18:39-54
116. Kadenbach B, Arnold S (1999) A second mechanism of respiratory control. FEBS Lett 447:131-134
117. Kadenbach B, Reimann A (1992) Cytochrome c oxidase: tissue-specific expression of isoforms and regulation of activity. In: Ernster L (ed) Molecular mechanisms in bioenergetics. Elsevier, Amsterdam, pp 241-263
118. Kadenbach B, Jarausch J, Hartmann R, Merle P (1983) Separation of mammalian cytochrome c oxidase into 13 polypeptides by a sodium dodecyl sulfate-gel electrophoretic procedure. Anal Biochem 129:517-521
119. Kadenbach B, Napiwotzki J, Frank V, Arnold S, Exner S, Huttemann M (1998) Regulation of energy transduction and electron transfer in cytochrome c oxidase by adenine nucleotides. J Bioenerg Biomembr 30:25-33
120. Kadenbach B, Huttemann M, Arnold S, Lee I, Bender E (2000) Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. Free Radic Biol Med 29:211-221
121. Kadenbach B, Arnold S, Lee I, Huttemann M (2004) The possible role of cytochrome c oxidase in stress- induced apoptosis and degenerative diseases. Biochim Biophys Acta 1655:400-408
122. Kadenbach B, Ramzan R, Vogt S (2009) Degenerative diseases, oxidative stress and cytochrome c oxidase function. Trends Mol Med 15:139-147
123. Kadenbach B, Ramzan R, Wen L, Vogt S (2010) New extension of the Mitchell Theory for oxidative phosphorylation in mitochondria of living organisms. Biochim Biophys Acta 1800:205-212
124. Kaim G, Dimroth P (1999) ATP synthesis by F-type ATP synthase is obligatorily dependent on the transmembrane voltage. EMBO J 18:4118-4127
125. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S (1995) Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. J Neurochem 65:2585-2593
126. Kanki T, Ohgaki K, Gaspari M, Gustafsson CM, Fukuoh A, Sasaki N, Hamasaki N, Kang D (2004) Architectural role of mitochondrial transcription factor A in maintenance of human mitochondrial DNA. Mol Cell Biol 24:9823-9834
127. Kato M, Saito H, Abe K (1997) Nanomolar amyloid beta protein-induced inhibition of cellular redox activity in cultured astrocytes. J Neurochem 68:1889-1895
128. Katzman R (1986) Alzheimer's disease. N Engl J Med 314:964-973
129. Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Hum Mol Genet 19:3919-3935
130. Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM, Nobrega JN (1992) Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 59:776-779
131. Klinge CM (2008) Estrogenic control of mitochondrial function and biogenesis. J Cell Biochem 105:1342-1351
132. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K (2006) Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38:518-520
133. Kruman II, Pedersen WA, Springer JE, Mattson MP (1999) ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol 160:28-39
134. Kunz WS, Kudin A, Vielhaber S, Elger CE, Attardi G, Villani G (2000) Flux control of cytochrome c oxidase in human skeletal muscle. J Biol Chem 275:27741-27745
135. Kwast KE, Burke PV, Poyton RO (1998) Oxygen sensing and transcriptional regulation of oxygenresponsive genes in yeast. J Exp Biol 201:1177-1195
136. Kwast KE, Burke PV, Staahl BT, Poyton RO (1999) Oxygen sensing in yeast: evidence for the involvement of the respiratory chain in regulating the transcription of a subset of hypoxic genes. Proc Natl Acad Sci USA 96:5446-5451
137. Lardy HA, Wellman H (1952) Oxidative phosphorylations; role of inorganic phosphate and acceptor systems in control of metabolic rates. J Biol Chem 195:215-224
138. LaSpada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
139. Lee HC, Pang CY, Hsu HS, Wei YH (1994) Differential accumulations of 4,977 bp deletion in mitochondrial DNA of various tissues in human ageing. Biochim Biophys Acta 1226:37-43
140. Lee I, Bender E, Arnold S, Kadenbach B (2001) New control of mitochondrial membrane potential and ROS formation - a hypothesis. Biol Chem 382:1629-1636
141. Lee I, Salomon AR, Ficarro S, Mathes I, Lottspeich F, Grossman LI, Huttemann M (2005) cAMPdependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J Biol Chem 280:6094-6100
142. Letellier T, Malgat M, Mazat JP (1993) Control of oxidative phosphorylation in rat muscle mitochondria: implications for mitochondrial myopathies. Biochim Biophys Acta 1141:58-64
143. Li Y, Park JS, Deng JH, Bai Y (2006) Cytochrome c oxidase subunit IV is essential for assembly and respiratory function of the enzyme complex. J Bioenerg Biomembr 38:283-291
144. Lightowlers RN, Chinnery PF, Turnbull DM, Howell N (1997) Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 13:450-455
145. Linnane AW, Marzuki S, Ozawa T, Tanaka M (1989) Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases. Lancet 1:642-645
146. Lowry OH (1975) Energy metabolism in brain and its control. In: Ingvar DH, Lassen NA (eds) Brain work: the coupling of function, metabolism, and blood flow in the brain-proceedings of the Alfred Benzon symposium VII. Academic, New York, pp 48-64
147. Ludwig B, Bender E, Arnold S, Huttemann M, Lee I, Kadenbach B (2001) Cytochrome c oxidase and the regulation of oxidative phosphorylation. Chembiochem 2:392-403
148. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H (2004) ABAD directly links A b to mitochondrial toxicity in Alzheimer's disease. Science 304:448-452
149. Malatesta F, Antonini G, Sarti P, Brunori M (1987) Modulation of cytochrome oxidase activity by inorganic and organic phosphate. Biochem J 248:161-165
150. Manczak M, Park BS, Jung Y, Reddy PH (2004) Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med 5:147-162
151. Manczak M, Jung Y, Park BS, Partovi D, Reddy PH (2005) Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging. J Neurochem 92:494-504
152. Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ, Rodriguez-Enriquez S, Moreno-Sanchez R (2009) HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 9:1084-1101
153. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147
154. Marsden CD (1990) Parkinson's disease. Lancet 335:948-952
155. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, Manfredi G (2002) Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 277:29626-29633
156. Mattingly KA, Ivanova MM, Riggs KA, Wickramasinghe NS, Barch MJ, Klinge CM (2008) Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol Endocrinol 22:609-622
157. Maurer I, Zierz S, Moller HJ (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 21:455-462
158. McGeer PL, McGeer EG (2008) Glial reactions in Parkinson's disease. Mov Disord 23:474-483
159. Menzies FM, Cookson MR, Taylor RW, Turnbull DM, Chrzanowska-Lightowlers ZMA, Dong L, Figlewicz DA, Shaw PJ (2002) Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 125:1522-1533
160. Misiak M, Beyer C, Arnold S (2010a) Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons. Biochim Biophys Acta 1797:1178-1188
161. Misiak M, Singh S, Drewlo S, Beyer C, Arnold S (2010b) Brain region-specific vulnerability of astrocytes in response to 3-nitropropionic acid is mediated by cytochrome c oxidase isoform expression. Cell Tissue Res 341:83-93
162. Mitchell P (1961) Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of mechanism. Nature 191:144-148
163. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) De ficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163:1450-1455
164. Muftuoglu M, Elibol B, Dalmizrak O, Ercan A, Kulaksiz G, Ogus H, Dalkara T, Ozer N (2004) Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord 19:544-548
165. Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1-13
166. Murphy MP, Brand MD (1987) Variable stoichiometry of proton pumping by the mitochondrial respiratory chain. Nature 329:170-172
167. Mutisya EM, Bowling AC, Beal MF (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 63:2179-2184
168. Napiwotzki J, Kadenbach B (1998) Extramitochondrial ATP/ADP-ratios regulate cytochrome c oxidase activity via binding to the cytosolic domain of subunit IV. Biol Chem 379:335-339
169. Napiwotzki J, Shinzawa-Itoh K, Yoshikawa S, Kadenbach B (1997) ATP and ADP bind to cytochrome c oxidase and regulate its activity. Biol Chem 378:1013-1021
170. Navarro A, Boveris A (2004) Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. Am J Physiol Regul Integr Comp Physiol 287:R1244-R1249
171. Navarro A, Boveris A (2007) The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 292:670-686
172. Nicholls DG, Ferguson SJ (2002) Bioenergetics, 3rd edn. Academic, London
173. Nilsen J (2008) Estradiol and neurodegenerative oxidative stress. Front Neuroendocrinol 29:463-475
174. Nilsen J, Irwin RW, Gallaher TK, Brinton RD (2007) Estradiol in vivo regulation of brain mitochondrial proteome. J Neurosci 27:14069-14077
175. Ongwijitwat S, Wong-Riley MT (2005) Is nuclear respiratory factor 2 a master transcriptional coordinator for all ten nuclear-encoded cytochrome c oxidase subunits in neurons? Gene 360:65-77
176. Ongwijitwat S, Liang HL, Graboyes EM, Wong-Riley MT (2006) Nuclear respiratory factor 2 senses changing cellular energy demands and its silencing down-regulates cytochrome oxidase and other target gene mRNAs. Gene 374:39-49
177. Ostermeier C, Harrenga A, Ermler U, Michel H (1997) Structure at 2.7 A resolution of the Paracoccus denitrificans two-subunit cytochrome c oxidase complexed with an antibody FV fragment. Proc Natl Acad Sci USA 94:10547-10553
178. Papa S, Capitanio N, Capitanio G, De Nitto E, Minuto M (1991) The cytochrome chain of mitochondria exhibits variable H+/e - stoichiometry. FEBS Lett 288:183-186
179. Parker WD Jr, Boyson SJ, Luder AS, Parks JK (1990a) Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology 40:1231-1234
180. Parker WD, Filley CM, Parks JK (1990b) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40:1302-1303
181. Parker WD Jr, Parks J, Filley CM, Kleinschmidt-DeMasters BK (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology 44:1090-1096
182. Pellerin L, Magistretti PJ (2004) Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neuroscientist 10:53-62
183. Peyser CE, Folstein M, Chase GA, Starkstein S, Brandt J, Cockrell JR, Bylsma F, Coyle JT, McHugh PR, Folstein SE (1995) Trial of d-alpha-tocopherol in Huntington's disease. Am J Psychiatry 152:1771-1775
184. Poyton RO, Goehring B, Droste M, Sevarino KA, Allen LA, Zhao XJ (1995) Cytochrome c oxidase from Saccharomyces cerevisiae . Methods Enzymol 260:97-116
185. Ramzan R, Staniek K, Kadenbach B, Vogt S (2010) Mitochondrial respiration and membrane potential are regulated by the allosteric ATP-inhibition of cytochrome c oxidase. Biochim Biophys Acta 1797:1672-1680
186. Reddy PH, Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: implication for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14:45-53
187. Reddy PH, Tripathy R, Troung Q, Thirumala K, Reddy TP, Anekonda V, Shirendeb UP, Calkins MJ, Reddy AP, Mao P, Manczak M (2011) Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta. doi:10.1016/j.bbadis.2011.10.011
188. Reimann A, Huther FJ, Berden JA, Kadenbach B (1988) Anions induce conformational changes and in fluence the activity and photoaf finity labeling by 8-azido-ATP of isolated cytochrome c oxidase. Biochem J 254:835-840
189. Ristow M, Zarse K (2010) How increase oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp Gerontol 45:410-418
190. Rodriguez-Navarro JA, Solano RM, Casarejos MJ, Gomez A, Perucho J, de Yebenes JG, Mena MA (2008) Gender differences and estrogen effects in parkin null mice. J Neurochem 106:2143-2157
191. Roemgens A, Singh S, Beyer C, Arnold S (2010) Inducers of chemical hypoxia act in a genderand brain region-specific manner on primary astrocyte viability and cytochrome c oxidase. Neurotox Res 20:1-14
192. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62
193. Sasaki S, Iwata M (1996) Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett 204:53-56
194. Sasaki S, Iwata M (2007) Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 66:10-16
195. Schagger H, Ohm TG (1995) Human diseases with defects in oxidative phosphorylation. 2. F1F0- ATP synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis (PAGE). Eur J Biochem 227:916-921
196. Schapira AH (1996) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr Opin Neurol 9:260-264
197. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z (2007) Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26:1749-1760
198. Sekeris CE (1990) The mitochondrial genome: a possible primary site of action of steroid hormones. In Vivo 4:317-320
199. Shearman MS, Hawtin SR, Tailor VJ (1995) The intracellular component of cellular 3-(4,5-dimethylthiazol- 2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. J Neurochem 65:218-227
200. Shi C, Xu J (2008) Increased vulnerability of brain to estrogen withdrawal-induced mitochondrial dysfunction with aging. J Bioenerg Biomembr 40:625-630
201. Shi C, Xu XW, Forster EL, Tang LF, Ge Z, Yew DT, Xu J (2008) Possible role of mitochondrial dysfunction in central neurodegeneration of ovariectomized rats. Cell Biochem Funct 26:172-178
202. Shigenaga MK, Hagen TM, Ames BN (1994) Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91:10771-10778
203. Shulman LM (2007) Gender differences in Parkinson's disease. Gend Med 4:8-18
204. Siklos L, Engelhardt J, Harati Y, Smith RG, Joo F, Appel SH (1996) Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann Neurol 39:203-216
205. Simonetti S, Chen X, DiMauro S, Schon EA (1992) Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim Biophys Acta 1180:113-122
206. Simonian NA, Hyman BT (1994) Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J Neuropathol Exp Neurol 53:508-512
207. Simpkins JW, Dykens JA (2008) Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev 57:421-430
208. Simpkins JW, Yang SH, Liu R, Perez E, Cai ZY, Covey DF, Green PS (2004) Estrogen-like compounds for ischemic neuroprotection. Stroke 35:2648-2651
209. Simpkins JW, Wang J, Wang X, Perez E, Prokai L, Dykens JA (2005) Mitochondria play a central role in estrogen-induced neuroprotection. Curr Drug Targets CNS Neurol Disord 4:69-83
210. Singh S, Misiak M, Beyer C, Arnold S (2009) Cytochrome c oxidase isoform IV-2 is involved in 3-nitropropionic acid-induced toxicity in striatal astrocytes. Glia 57:1480-1491
211. Singh S, Misiak M, Beyer C, Arnold S (2010) Brain region specificity of 3-nitropropionic acidinduced vulnerability of neurons involves cytochrome c oxidase. Neurochem Int 57:297-305
212. Soong NW, Hinton DR, Cortopassi G, Arnheim N (1992) Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet 2:318-323
213. Stirone C, Duckles SP, Krause DN, Procaccio V (2005) Estrogen increases mitochondrial ef ficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol 68:959-965
214. Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire JP, Bennett JP, Davis RE, Parker WD (1997) Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49:918-925
215. Swerdlow RH, Parks JK, Cassarino DS, Trimmer PA, Miller SW, Maguire DJ, Sheehan JP, Maguire RS, Pattee G, Juel VC, Phillips LH, Tuttle JB, Bennett JP Jr, Davis RE, Parker WD Jr (1998) Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol 153:135-142
216. Tabrizi SJ, Cleeter M, Xuereb J, Taanman JW, Cooper JM, Schapira AVH (1999) Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol 45:25-32
217. Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, Trillat AC, Stern DM, Arancio O, Yan SS (2005) ABAD enhances A b -induced cell stress via mitochondrial dysfunction. FASEB J 19:597-598
218. Taylor CT, Moncada S (2010) Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol 30:643-647
219. Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, Yaono R, Yoshikawa S (1996) The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science 272:1136-1144
220. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84
221. van den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157:1015-1022
222. Villani G, Attardi G (1997) In vivo control of respiration by cytochrome c oxidase in wild-type and mitochondrial DNA mutation-carrying human cells. Proc Natl Acad Sci USA 94:1166-1171
223. Villani G, Attardi G (2000) In vivo control of respiration by cytochrome c oxidase in human cells. Free Radic Biol Med 29:202-210
224. Villani G, Greco M, Papa S, Attardi G (1998) Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types. J Biol Chem 273:31829-31836
225. Virbasius JV, Scarpulla RC (1994) Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci USA 91:1309-1313
226. Wallace DC, Fan W, Procaccio V (2010) Mitochondrial energetics and therapeutics. Annu Rev Pathol 5:297-348
227. Watanabe T, Inoue S, Hiroi H, Orimo A, Kawashima H, Muramatsu M (1998) Isolation of estrogen responsive genes with a CpG island library. Mol Cell Biol 18:442-449
228. West MJ (1993) Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging 14:287-293
229. West M, Coleman P, Flood D, Tronsco J (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344:769-772
230. Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, Kunz WS (1998) Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 156:65-72
231. Wilson DF, Mokashi A, Chugh D, Vinogradov S, Osanai S, Lahiri S (1994) The primary oxygen sensor of the cat carotoid body is cytochrome a3 of the mitochondrial respiratory chain. FEBS Lett 351:370-374
232. Wong-Riley MTT (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94-101
233. Wong-Riley M, Antuono P, Ho KC, Egan R, Hevner R, Liebl W, Huang Z, Rachel R, Jones J (1997) Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res 37:3593-3608
234. Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J (2004) Are men at greater risk for Parkinson's disease than women? J Neurol Neurosurg Psychiatry 75:637-639
235. Yang SH, Liu R, Perez EJ, Wen Y, Stevens SM Jr, Valencia T, Brun-Zinkernagel AM, Prokai L, Will Y, Dykens J, Koulen P, Simpkins JW (2004) Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci USA 101:4130-4135
236. Yoshikawa S, Shinzawa-Itoh K, Tsukihara T (1998) Crystal structure of bovine heart cytochrome c oxidase at 2.8 A resolution. J Bioenerg Biomembr 30:7-14
237. Zeng H, Chen Q, Zhao B (2004) Genistein ameliorates beta-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis. Free Radic Biol Med 36:180-188
238. Zhao L, Wu TW, Brinton RD (2004) Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res 1010:22-34
239. Zhao L, Jin C, Mao Z, Gopinathan MB, Rehder K, Brinton RD (2007) Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator-a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons. J Med Chem 50:4471-4481
240. Zhao L, Mao Z, Brinton RD (2009) A select combination of clinically relevant phytoestrogens enhances estrogen receptor {beta}-binding selectivity and neuroprotective activities in vitro and in vivo. Endocrinology 150:770-783
241. Zhou J, Zhou L, Hou D, Tang J, Sun J, Bondy SC (2011) Paeonol increases levels of cortical cytochrome oxidase and vascular actin and improves behavior in a rat model of Alzheimer's disease. Brain Res 1388:141-147